1Ball P. Quinolone generations: natural history or natural selection[J]? J Antimicrob Chemother, 2000, 46(Suppl T1):17- 24.
2Zhanel GG, Ennis K, Vercaigne L, et al. A critical review of the fluoroquinolones: focus on respiratory infections [J].Drugs, 2002, 62(1):13-59.
3Stahlmann R, Lode H. Toxicity of quinolones[J]. Drugs,1999, 58 (Suppl 2):37-42.
4Belvedere A, Bosca F, Catalfo A, et al. Type Ⅱ guanine oxidation photoinduced by the antibacterial fluoroquinolone rufloxacin in isolated DNA and in 2'-deoxyguanosine [J].Chem Res Toxicol, 2002, 15(9):1142- 1149.
5Ravanat JL, Douki T, Cadet J. Direct and indirect effects of UV radiation on DNA and its components[J]. J Photochem Photobiol B, 2001, 63(1-3):88-102.
6Spiehnann H, Balls M, Dupuis J, et al. EU/COLIPA "In vitro phototoxicity" validation study, results of phase Ⅱ (blind trial), part 1: the 3T3 NRU phototoxicity test[J].Toxicol In Vitro, 1998, 12:305 - 327.
7Kessel D, Caruso JA, Reiners JJ Jr. Potentiation of photodynamic therapy by ursodeoxycholic acid[J]. Cancer Res,2000, 60(24), 6985- 6988.
8Rancan F, Rosan S, Boehm F, et al. Cytotoxicity and photocytotoxicity of a dendritic C6o mono-adduct and a malonic acid C60 tris-adduct on Jurkat cells[J]. J Photochem Photobiol B, 2002, 67(3): 157 - 162.
9Meunier JR, Sarasin A, Marrot L. Photogenotoxicity of mammalian cells: a review of the different assays forin vitro testing[J]. Photochem Photobiol, 2002, 75(5):437-447.
10Siami G, Christou N, Eiseman I, et al. Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections [J]. Antimicrob Agents Chemother, 2001, 45(2) :525 - 531.
